Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Juan Jesus Perez"'
Autor:
Neda Razzaghi, Pol Fernandez-Gonzalez, Aina Mas-Sanchez, Guillem Vila-Julià, Juan Jesus Perez, Pere Garriga
Publikováno v:
Molecules, Vol 26, Iss 10, p 3032 (2021)
Rhodopsin is the G protein-coupled receptor of rod photoreceptor cells that mediates vertebrate vision at low light intensities. Mutations in rhodopsin cause inherited retinal degenerative diseases such as retinitis pigmentosa. Several therapeutic st
Externí odkaz:
https://doaj.org/article/62ee022c99b547fea591167445101a0c
Autor:
Juan Jesus Perez
Publikováno v:
ResearcherID
Autor:
Jose Carlos, Flores-González, Maria Teresa, Dominguez-Coronel, Miguel Angel, Matamala Morillo, Miriam, Aragón Ramírez, Rosa María, García Ortega, Francisco Javier, Dávila Corrales, Maria Victoria, García Palacios, Juan Jesus, Perez Guerrero, Laura, García García, Alfonso María, Lechuga Sancho
Publikováno v:
Minerva pediatrica. 68(2)
Nebulized 3% hypertonic saline solution (HSS 3%) has proven to reduce hospital stay in infants with acute bronchiolitis, as compared with nebulized physiological saline solutions. There are no studies assessing the effectiveness of nebulized epinephr
Autor:
Tomas Roca, Juan-Lorenzo Catena, Joan Bosch, Ignasi Miquel, Oriol Llorens, Ana Fernandez‐Serrat, Juan‐Jesus Perez, A.G. Fernández, Carmen Lagunas, Carles Farrerons
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 10:1745-1748
The synthesis and structure–activity relationships (SAR) of a series of novel selective COX-2 inhibitors are reported. The results show that some of the 1,3,4-triaryl-3-pyrrolin-2-ones 1 are more potent as COX-2 inhibitors than celecoxib, and that
Autor:
Carles Farrerons, Ana Fernandez‐Serrat, Joan Bosch, Juan‐Jesus Perez, Juan-Lorenzo Catena, Ignasi Miquel, Oriol Llorens, A.G. Fernández, Carmen Lagunas, Tomas Roca
Publikováno v:
ChemInform. 31
The synthesis and structure–activity relationships (SAR) of a series of novel selective COX-2 inhibitors are reported. The results show that some of the 1,3,4-triaryl-3-pyrrolin-2-ones 1 are more potent as COX-2 inhibitors than celecoxib, and that
Autor:
Herrera Hernandez, Maria Guadalupe, Dong, Xiaoyun, Lupala, Cecylia S., Juan Jesus Perez, Garriga, Pere
Publikováno v:
Publons
ResearcherID
ResearcherID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4e00dd090e07cc0d42d731b0eb096fc9
https://publons.com/publon/5770153/
https://publons.com/publon/5770153/